Stock Market Live June 16: S&P 500 (SPY) Could Easily Rally to Higher Highs
NVO sits 44% below its 52-week high with a price-to-free-cash-flow of 5 and a free cash flow yield above 20%.
XLV's flat 2026 performance masks CVS trading at a forward P/E of 14 with 86% analyst buy ratings and zero sell ratings.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and AbbVie didn't make the cut. Grab the names FREE today.
© 24/7 Wall St.
Healthcare has spent 2026 on the sidelines while the rest of the market does the heavy lifting. The Health Care Select Sector SPDR Fund (NYSEARCA:XLV) is down around 1% year to date even after a 6% one-month bounce. That stagnation has left a handful of high-margin operators trading at forward multiples that look out of step with their cash generation. Here are three to put on the radar this month.
Joel South covers large-cap stocks, dividend investing, and major market trends, with a focus on earnings analysis, valuation, and turning complex data into actionable insights for investors.
He brings more than 15 years of experience as an investor and financial journalist, including 12 years at The Motley Fool, where he served as an investment analyst, Bureau Chief, and later led the Fool.com investing news desk. He has also co-hosted an investing podcast and appeared across TV and radio discussing market trends.
Our top personal finance-related articles today. Your wallet will thank you later.
Top Gaining Stocks
Top Losing Stocks